Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
threonate (3 trials)
nrct-101 (1 trial)
Alzheimer Disease (Phase 2)
Attention Deficit Disorder with Hyperactivity (Phase 2)
Hyperkinesis (Phase 2)
Psychotic Disorders (Phase 4)
Schizophrenia (Phase 4)
Trials (4 total)
Trial APIs (2 total)